GE HealthCare stock slips as options signal turns cautious
Published on 09/04/2026 at 12:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GE HealthCare Technologies (ISIN US36266G1076) stock closed at 69.72 USD on September 3, 2026, down 1.19 percent on the day and extending a pullback from recent levels above 71 USD, according to price data compiled by Forbes.
Options signal adds pressure
Market data highlighted on September 3, 2026 indicates that GE HealthCare stock has triggered a new sell signal based on the put to call ratio, reflecting a shift toward more protective positioning in the options market, as reported by MarketWatch.
In practical terms, a rising put to call ratio means more investors are buying put options to hedge or speculate on declines than call options, a pattern that can amplify short term pressure on the share price when sentiment turns cautious.
Earnings and guidance frame the story
Healthcare technology company GE HealthCare Technologies reported Q4 calendar year 2025 revenue of 5,700,000,000 USD, up 7.1 percent year on year from roughly 5,320,000,000 USD, and 1.44 USD in adjusted EPS, beating analyst expectations of 1.40 USD per share, according to a recent research report from StockStory.
The same analysis notes that GE HealthCare’s Q4 2025 revenue exceeded Wall Street estimates by 1.7 percent, underlining that the company entered 2026 with solid demand for imaging and diagnostic systems and a demonstrable ability to deliver modest earnings beats.
For the upcoming financial year 2026, GE HealthCare has signaled adjusted EPS guidance of 5.05 USD at the midpoint, which stands about 2.5 percent above the average analyst estimate cited in the report, suggesting management is targeting continued profit growth even as markets scrutinize valuation more closely.
On valuation, the StockStory overview puts GE HealthCare at 69.12 USD per share on a forward price to earnings multiple of 14.1, a level that implies the market is pricing the stock more like a mature industrial rather than a high growth medtech name despite the mid single digit revenue growth.
Insider tax withholding gives a price reference
Regulatory filings show that on September 1, 2026, GE HealthCare used a share value of 71.23 USD for common stock when calculating tax withholding on vested restricted stock units for senior executives, including 3,131 shares withheld for Frank R. Jimenez and 856 shares for Philip Rackliffe, according to SEC Form 4 summaries compiled by StockTitan.
These filings confirm that as of September 1, 2026, GE HealthCare shares were valued above 71 USD for internal compensation purposes, offering investors a recent reference point just days before the closing price fell back to 69.72 USD on September 3, 2026.
Product focus: imaging and AI in interventional radiology
Beyond the stock metrics, GE HealthCare is positioning its imaging platforms and artificial intelligence driven guidance solutions at major medical conferences in 2026, with healthcare in Europe reporting on September 4, 2026 that AI segmentation and robotic guidance for interventional procedures are being showcased with participation from GE HealthCare among other vendors.
These systems are designed to assist clinicians in planning and navigating minimally invasive treatments, a segment where improved imaging quality and algorithm based segmentation can translate directly into better outcomes and, over time, recurring equipment and service revenue for companies like GE HealthCare.
Stock level and investor view
As of the close on September 3, 2026, GE HealthCare stock stands at 69.72 USD on the NASDAQ, near the level cited in recent valuation and technical snapshots and below the 71.23 USD reference price implied by insider tax withholding earlier in the week.
GE HealthCare stock at a glance
- Company: GE HealthCare Technologies Inc.
- ISIN: US36266G1076
- Ticker: GEHC
- Trading venue: NASDAQ
- Price (as of September 3, 2026, 16:00): 69.72 USD
- Sector / Industry: Health Care Equipment and Services
- Index membership: S&P 500
